Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT03055494
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent must be obtained before any assessment is performed
* Clinical diagnosis of chronic plaque-type psoriasis at least 6 months prior to randomization
* Moderate to severe plaque psoriasis as defined at baseline by:
* ≥10% Body Surface Area (BSA) involvement and
* PASI total score of ≥12 and
* IGA mod 2011 score of ≥3 (based on a scale of 0-4)
Exclusion Criteria:
* Forms of diagnosed psoriasis other than chronic plaque psoriasis
* Medication-induced or medication exacerbated psoriasis
* Previous exposure to secukinumab or any other biologic drug directly targeting IL-17A or IL-17RA receptors
* Ongoing use of prohibited treatments
* Pregnant or nursing (lactating) women
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03055494
Study Brief:
Protocol Section:
NCT03055494